Clincosm LogoSign in Get a demo

tardive dyskinesia

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities Trial in Cleveland (Valbenazine Oral Capsule)

Not yet recruiting
  • Tardive Dyskinesia
  • +2 more
  • Valbenazine Oral Capsule
  • Cleveland, Ohio
    University Hospitals of Cleveland
Oct 30, 2023

Tardive Dyskinesia Trial in Brooklyn, Garfield Heights (TDtect)

Recruiting
  • Tardive Dyskinesia
  • TDtect
  • Brooklyn, New York
  • +1 more
Aug 21, 2023

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial (Valbenazine)

Not yet recruiting
  • Schizophrenia
  • +4 more
  • (no location specified)
May 5, 2023

Movement Disorders, Essential Tremor, Holmes Tremor Trial in Toronto (Transcranial ExAblate System)

Active, not recruiting
  • Movement Disorders
  • +8 more
  • Transcranial ExAblate System
  • Toronto, Ontario, Canada
  • +1 more
Dec 19, 2022

Tardive Dyskinesia Trial in Suzhou (Active tDCS, Sham tDCS)

Completed
  • Tardive Dyskinesia
  • Active tDCS
  • Sham tDCS
  • Suzhou, Jiangsu, China
  • +1 more
Aug 19, 2022

Tardive Dyskinesia Trial (Valbenazine)

Not yet recruiting
  • Tardive Dyskinesia
  • (no location specified)
May 23, 2022

Tardive Dyskinesia, Antipsychotic Agents Trial in Chapel Hill (Pyridoxine, Placebo)

Recruiting
  • Tardive Dyskinesia
  • Antipsychotic Agents
  • Pyridoxine
  • Placebo
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Apr 12, 2022

Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

Completed
Has Results
  • Tardive Dyskinesia
  • Tuscaloosa, Alabama
  • +81 more
Mar 31, 2022

Huntington Disease, Tardive Dyskinesia Trial in Shanghai (LPM3770164 sustained release tablet, LPM3770164 sustained release

Not yet recruiting
  • Huntington Disease
  • Tardive Dyskinesia
  • LPM3770164 sustained release tablet
  • LPM3770164 sustained release tablet simulant
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Feb 3, 2022

Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

Completed
Has Results
  • Tardive Dyskinesia
  • Tuscaloosa, Alabama
  • +40 more
Nov 5, 2021

Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

Completed
Has Results
  • Tardive Dyskinesia
  • Tuscaloosa, Alabama
  • +105 more
Nov 5, 2021

Tourette Syndrome, Tardive Dyskinesia Trial in Houston (Pimavanserin)

Completed
  • Tourette Syndrome
  • Tardive Dyskinesia
  • Houston, Texas
    Baylor College of Medicine
Mar 10, 2021

Tardive Dyskinesia Trial in Japan (MT-5199, Placebo)

Completed
  • Tardive Dyskinesia
  • Aichi, Japan
  • +81 more
Oct 7, 2020

Schizophrenia, Schizoaffective Disorder, Tobacco Smoking Trial in Philadelphia (Varenicline)

Unknown status
  • Schizophrenia
  • +4 more
  • Philadelphia, Pennsylvania
    Corporal Michael J Crescenz VA Medical Center
Mar 20, 2019

Tardive Dyskinesia Trial (Propranolol Hydrochloride, Placebo Oral Tablet)

Withdrawn
  • Tardive Dyskinesia
  • Propranolol Hydrochloride
  • Placebo Oral Tablet
  • (no location specified)
Feb 22, 2019

Tardive Dyskinesia Trial in Canada, India (Pyridoxal 5'-Phosphate, Placebo)

Terminated
  • Tardive Dyskinesia
  • Pyridoxal 5'-Phosphate
  • Placebo
  • Victoria, British Columbia, Canada
  • +3 more
Feb 11, 2019

Tardive Dyskinesia Trial in United States (Valbenazine)

Completed
Has Results
  • Tardive Dyskinesia
  • Anaheim, California
  • +26 more
Nov 28, 2018

Tardive Dyskinesia Trial in Canada, Puerto Rico, United States (NBI-98854)

Completed
Has Results
  • Tardive Dyskinesia
  • Anaheim, California
  • +47 more
Nov 29, 2018

Schizophrenia and Schizoaffective Disorder, Tardive Dyskinesia Trial in Jerusalem (D-serine, Placebo)

Unknown status
  • Schizophrenia and Schizoaffective Disorder
  • Tardive Dyskinesia
  • D-serine
  • Placebo
  • Jerusalem, Israel
    Herzog Hospital
Oct 9, 2018

Tardive Dyskinesia Trial in Shanghai (Repetitive Transcranial Magnetic Stimulation)

Unknown status
  • Tardive Dyskinesia
  • Repetitive Transcranial Magnetic Stimulation
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center, Shanghai Jiao Tong University Sch
Feb 22, 2018

Tardive Dyskinesia Trial in United States

Unknown status
  • Tardive Dyskinesia
    • Little Rock, Arkansas
    • +33 more
    Nov 20, 2017

    Tardive Dyskinesia Trial in Puerto Rico, United States (NBI-98854, Placebo)

    Completed
    Has Results
    • Tardive Dyskinesia
    • Little Rock, Arkansas
    • +50 more
    Oct 9, 2017

    Tardive Dyskinesia Trial in France (Tetrabenazine, Placebo)

    Completed
    • Tardive Dyskinesia
    • Amiens, Picardie, France
    • +18 more
    Sep 11, 2017

    Tardive Dyskinesia Trial in United States (NBI-98854, Placebo)

    Completed
    Has Results
    • Tardive Dyskinesia
    • Little Rock, Arkansas
    • +10 more
    Jul 14, 2017

    Tardive Dyskinesia Trial in Puerto Rico, United States (NBI-98854, Placebo)

    Completed
    Has Results
    • Tardive Dyskinesia
    • Costa Mesa, California
    • +21 more
    Jul 11, 2017